Willem Adriaan de Jongh
Oprichter bij ExpreS2ion Biotechnologies ApS
Profiel
Willem Adriaan de Jongh is the founder of ExpreS2ion Biotechnologies ApS, founded in 2009, where he holds the title of Chief Scientific Officer.
He was also the founder of Expres2ion Biotech Holding AB, founded in 2010, where he held the title of Chief Scientific Officer until 2020.
Currently, he is the Chief Executive Officer & Director at Adaptvac ApS since 2017.
Dr. de Jongh received his doctorate degree from the Technical University of Denmark in 2006 and his undergraduate and graduate degrees from the University of Stellenbosch.
Actieve functies van Willem Adriaan de Jongh
Bedrijven | Functie | Begin |
---|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Oprichter | 01-01-2009 |
Adaptvac ApS | Algemeen Directeur | 01-01-2017 |
Eerdere bekende functies van Willem Adriaan de Jongh
Bedrijven | Functie | Einde |
---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Oprichter | 01-12-2020 |
Opleiding van Willem Adriaan de Jongh
University of Stellenbosch | Graduate Degree |
Technical University of Denmark | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
Adaptvac ApS |